China has become more accepting of Western medicines and sees the value of a strong patenting process, opening the door for more foreign trade and mutual benefits.
Innovative channels now take 60% of share compared with traditional channels for medical communication in China, reports Adele Li of Kantar Health, and doctors’ willingness to engage with pharma companies online is a cause for optimism for those working in the region. Read the full article in the latest edition of pharmaphorum's Deep Dive: Digital magazine.